Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

M. Cuffe; R. Califf; K. Adams; R. Benza; R. Bourge; W. Colucci; B. Massie; C. O'Connor; I. Pina; R. Quigg; M. Silver; Mihai Gheorghiade; Marcus G. Hennersdorf

doi:10.1054/ebcm.2002.0490

Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

M. Cuffe, R. Califf, K. Adams, R. Benza, R. Bourge, W. Colucci, B. Massie, C. O'Connor, I. Pina, R. Quigg, M. Silver, Mihai Gheorghiade, Marcus G. Hennersdorf

Medicine

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	154-155
Number of pages	2
Journal	Evidence-based Cardiovascular Medicine
Volume	6
Issue number	4
DOIs	https://doi.org/10.1054/ebcm.2002.0490
State	Published - Dec 2002

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1054/ebcm.2002.0490

Cite this

Cuffe, M., Califf, R., Adams, K., Benza, R., Bourge, R., Colucci, W., Massie, B., O'Connor, C., Pina, I., Quigg, R., Silver, M., Gheorghiade, M., & Hennersdorf, M. G. (2002). Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure. Evidence-based Cardiovascular Medicine, 6(4), 154-155. https://doi.org/10.1054/ebcm.2002.0490

Cuffe, M, Califf, R, Adams, K, Benza, R, Bourge, R, Colucci, W, Massie, B, O'Connor, C, Pina, I, Quigg, R, Silver, M, Gheorghiade, M & Hennersdorf, MG 2002, 'Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure', Evidence-based Cardiovascular Medicine, vol. 6, no. 4, pp. 154-155. https://doi.org/10.1054/ebcm.2002.0490

@article{849a765b0d614c6b9abaa3a07fa0009d,

title = "Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure",

author = "M. Cuffe and R. Califf and K. Adams and R. Benza and R. Bourge and W. Colucci and B. Massie and C. O'Connor and I. Pina and R. Quigg and M. Silver and Mihai Gheorghiade and Hennersdorf, {Marcus G.}",

year = "2002",

month = dec,

doi = "10.1054/ebcm.2002.0490",

language = "English (US)",

volume = "6",

pages = "154--155",

journal = "Evidence-based Cardiovascular Medicine",

issn = "1361-2611",

publisher = "Churchill Livingstone",

number = "4",

}

TY - JOUR

T1 - Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

AU - Cuffe, M.

AU - Califf, R.

AU - Adams, K.

AU - Benza, R.

AU - Bourge, R.

AU - Colucci, W.

AU - Massie, B.

AU - O'Connor, C.

AU - Pina, I.

AU - Quigg, R.

AU - Silver, M.

AU - Gheorghiade, Mihai

AU - Hennersdorf, Marcus G.

PY - 2002/12

Y1 - 2002/12

UR - http://www.scopus.com/inward/record.url?scp=3142664683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142664683&partnerID=8YFLogxK

U2 - 10.1054/ebcm.2002.0490

DO - 10.1054/ebcm.2002.0490

M3 - Short survey

AN - SCOPUS:3142664683

VL - 6

SP - 154

EP - 155

JO - Evidence-based Cardiovascular Medicine

JF - Evidence-based Cardiovascular Medicine

SN - 1361-2611

IS - 4

ER -

Intravenous milrinone is no better than standard therapy for people admitted with acute exacerbation of chronic heart failure

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this